Výsledky vyhledávání - "Y. A. Elsayed"

Akademický článek

Targeted Neonatal Echocardiography-Guided Therapy in Vein of Galen Aneurysmal Malformation: A Report of Two Cases with a Review of Physiology and Approach to Management

Autor: R. E. Giesinger, Y. N. Elsayed, M. P. Castaldo, P. J. McNamara

Publikováno v: American Journal of Perinatology Reports, Vol 09, Iss 02, Pp e172-e176 (2019)

Vein of Galen malformation results in predictable changes in physiology which exist on a continuum. Severe pulmonary hypertension may present as hypoxemia; however, excessive reduction in pulmonary vascular resistance may precipitate progressive pulm

Externí odkaz: https://doaj.org/article/22b0b46f6dd24b08ab555b9f4161e003

Zobrazit plný text záznamu

Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies

Autor: D. Cleere, S. Eppers, E. Rivera, Lia Gore, J. Li, S. L. Moulder-Thompson, Cindy L. O'Bryant, Michele Basche, S. G. Eckhardt, S. Grolnic, Y. A. Elsayed

Publikováno v: Investigational New Drugs. 30:1942-1949

Background To determine the maximum tolerated dose (MTD), safety and pharmacokinetics of trabectedin with capecitabine in patients with advanced malignancies. Design In this Phase I, open-label, dose-finding study, patients refractory to standard the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb0bfce5063940f6885c0737467d5447
https://doi.org/10.1007/s10637-011-9747-9

Zobrazit plný text záznamu

Phase I combination study of trabectedin (T) and capecitabine (C) in patients with advanced malignancies

Autor: Scott N. Holden, D. Cleere, Y. A. Elsayed, S. Grolnic, K. Lavallee, S. G. Eckhardt, S. L. Moulder, E. Rivera, Lia Gore

Publikováno v: Journal of Clinical Oncology. 24:2079-2079

2079 Background: T binds to the minor groove of DNA, synergizes with functional nuclease excision repair and targets inducible transcription. T is active in several tumor types and exhibits preclinical synergy with C. The primary objective of this st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::051333b28b921d00929e057a03aa3591
https://doi.org/10.1200/jco.2006.24.18_suppl.2079

Zobrazit plný text záznamu

A phase I/II trial of 13-cis retinoic acid, alpha interferon, docetaxel, and estramustine (R.I.T.E.) for the treatment of hormone refractory prostate cancer (HRPC)

Autor: E. Teller, A. Altscher, B. Hillard, Susan Goodin, S. Doyle-Lindrud, Robert S. DiPaola, Weichung Joe Shih, Y. A. Elsayed, Eric H. Rubin

Publikováno v: Journal of Clinical Oncology. 22:4707-4707

Advanced prostate cancer is only temporarily controlled with androgen ablation therapy. In order to overcome tumor resistance, we developed a epithelial cell line model to dissect out important mechanisms of resistance such as mutations in p53 and bc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37acf1f0059c68806e380ed64d2e391a
https://doi.org/10.1200/jco.2004.22.90140.4707

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání